164 related articles for article (PubMed ID: 2069771)
21. The impact of the UNOS mandatory sharing policy on recipients of the black and white races--experience at a single renal transplant center.
Barger B; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Phillips MG; Julian BA; Gaston RS; Laskow DA
Transplantation; 1992 Apr; 53(4):770-4. PubMed ID: 1566342
[TBL] [Abstract][Full Text] [Related]
22. Myasthenia gravis and HLA antigens in American blacks and other races.
Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
[TBL] [Abstract][Full Text] [Related]
23. Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure.
Doxiadis II; De Lange P; De Vries E; Persijn GG; Claas FH
Tissue Antigens; 2001 Apr; 57(4):344-7. PubMed ID: 11380944
[TBL] [Abstract][Full Text] [Related]
24. HLA antigens in White and Black South African diabetics.
Shires R; Maier G; Lustig A; Barnett P; Joffe BI; Seftel HC
S Afr Med J; 1983 Dec; 64(28):1087-9. PubMed ID: 6582605
[TBL] [Abstract][Full Text] [Related]
25. Human histocompatibility antigen associations in patients with chronic cutaneous lupus erythematosus.
Fowler JF; Callen JP; Stelzer GT; Cotter PK
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):73-7. PubMed ID: 3856581
[TBL] [Abstract][Full Text] [Related]
26. Immunogenetic factors that may contribute to ethnic differences in renal allograft survival.
Ward FE; MacQueen JM
Clin Transplant; 1996 Dec; 10(6 Pt 2):620-4. PubMed ID: 8996754
[TBL] [Abstract][Full Text] [Related]
27. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics.
Hall RP; Clark RE; Ward FE
J Am Acad Dermatol; 1990 Mar; 22(3):436-9. PubMed ID: 2312829
[TBL] [Abstract][Full Text] [Related]
28. HLA and multiple myeloma among black and white men: evidence of a genetic association.
Pottern LM; Gart JJ; Nam JM; Dunston G; Wilson J; Greenberg R; Schoenberg J; Swanson GM; Liff J; Schwartz AG
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):177-82. PubMed ID: 1306102
[TBL] [Abstract][Full Text] [Related]
29. The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry.
Zachary AA; Steinberg AG; Bias WB; Leffell MS
Transplantation; 1996 Jul; 62(2):272-83. PubMed ID: 8755828
[TBL] [Abstract][Full Text] [Related]
30. Effect of race on renal transplant outcome.
Hariharan S; Schroeder TJ; First MR
Clin Transplant; 1993 Jun; 7(3):235-9. PubMed ID: 10148842
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
[TBL] [Abstract][Full Text] [Related]
32. Hypertension as a cause of end-stage renal failure in South Africa.
Veriava Y; du Toit E; Lawley CG; Milne FJ; Reinach SG
J Hum Hypertens; 1990 Aug; 4(4):379-83. PubMed ID: 2258879
[TBL] [Abstract][Full Text] [Related]
33. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.
Hochberg MC; Boyd RE; Ahearn JM; Arnett FC; Bias WB; Provost TT; Stevens MB
Medicine (Baltimore); 1985 Sep; 64(5):285-95. PubMed ID: 2412088
[TBL] [Abstract][Full Text] [Related]
34. Immunogenetic and racial determinants of gold toxicity in rheumatoid arthritis.
Fraser PA; Stern SH; Coblyn JS; Weinblatt ME; Holdsworth DE; Green P; Shriner S; Mindnich D; Larson M
J Natl Med Assoc; 1988 Feb; 80(2):162-5. PubMed ID: 2977188
[TBL] [Abstract][Full Text] [Related]
35. Disease effects and associations.
Mitsuishi Y; Cecka JM
Clin Transpl; 1992; ():371-81. PubMed ID: 1306713
[TBL] [Abstract][Full Text] [Related]
36. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis.
Manabe K; Donaldson PT; Underhill JA; Doherty DG; Mieli-Vergani G; McFarlane IG; Eddleston AL; Williams R
Hepatology; 1993 Dec; 18(6):1334-7. PubMed ID: 8244257
[TBL] [Abstract][Full Text] [Related]
37. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.
Flack JM; Neaton JD; Daniels B; Esunge P
Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):31-40. PubMed ID: 8465834
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in the incidence of end-stage renal disease.
Tell GS; Hylander B; Craven TE; Burkart J
Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
[TBL] [Abstract][Full Text] [Related]
39. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
McClellan W; Tuttle E; Issa A
Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries.
Xue JL; Eggers PW; Agodoa LY; Foley RN; Collins AJ
J Am Soc Nephrol; 2007 Apr; 18(4):1299-306. PubMed ID: 17329578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
